How do I explain to a Spanish-speaking HIV patient that undetectable does not mean cured?

The patient who read about U=U (Undetectable equals Untransmittable) and concluded the virus is gone is not being irrational. The article he read is scientifically accurate about one thing: a person with a sustained undetectable viral load on antiretroviral therapy cannot sexually transmit HIV. That is true and important. The inference that followed — that undetectable means the virus has been eliminated — is the error, and it is a very natural one. The conversation starts by validating the part that is correct: “Lo que leyó sobre indetectable igual a intransmisible es verdad — cuando el virus está indetectable, no puede transmitirse sexualmente. Eso es real y es una de las razones más importantes para mantener el medicamento.” Then the distinction: “Indetectable no significa que el virus desapareció. Significa que el medicamento lo está controlando tan bien que los equipos más sensibles que tenemos no pueden encontrarlo en la sangre. Pero el virus está ahí — en células del sistema inmune donde se quedó dormido. Si deja el medicamento, el virus comienza a reproducirse de nuevo. Su carga viral de hoy — 2,400 copias — es la prueba de lo que pasa cuando el medicamento no está.” The concrete evidence is the viral load result. A patient who had fourteen consecutive months of undetectable results and has 2,400 copies after eight weeks without the medication can see, in a number, exactly what the medication was doing. The goal of the conversation is not to assign blame for stopping. The goal is to make the mechanism legible: the medication holds the virus in a state where it cannot replicate; the moment the medication stops, the virus resumes replicating. There is no cure yet. Indetectable is the medication working, not the infection gone.

How do I explain to a Spanish-speaking tuberculosis patient why she has to keep taking all four medications even though she feels completely better?

The tuberculosis patient who stopped RIPE therapy at week five because her symptoms resolved has a completely reasonable model of how medication works: you feel sick, you take medicine, the medicine makes you better, you stop when you feel better. That model is correct for almost every other infection a person encounters in her life. It is specifically wrong for tuberculosis, and the nurse’s job is to explain why — not to correct an error, but to add information that the patient has never had a reason to know. “La razón por la que se siente mejor después de tres o cuatro semanas es que los primeros dos meses de tratamiento están matando las bacterias que están activas — las que se están multiplicando rápido, las que producen la tos, la fiebre, el sudor. Cuando esas bacterias mueren, los síntomas desaparecen. Eso es bueno. Eso quiere decir que el tratamiento está funcionando. El problema es que dentro del pulmón hay otro grupo de bacterias de tuberculosis que están dormidas — no se están dividiendo, no están causando síntomas, no las siente, pero están ahí. Esas bacterias dormidas no las matan los mismos dos meses. Los cuatro meses que siguen después son específicamente para matarlas a ellas. Si para el tratamiento ahora — cuando las activas ya murieron pero las dormidas están todavía ahí — las dormidas despiertan. Y cuando despiertan después de haber estado expuestas a los medicamentos, pueden haberse vuelto resistentes. Eso significa que el segundo tratamiento es mucho más difícil, mucho más largo, y tiene más efectos secundarios.” The key phrase is “bacterias dormidas” — dormant bacteria. Most patients have never heard of the concept that a living bacterium can persist in a non-replicating state inside the lung. Once the patient understands that feeling better is the first two months working, not the infection over, the instruction to keep taking the medication for four more months has a reason behind it rather than just being an instruction she has to follow.

How do I explain to a Spanish-speaking hepatitis C patient that being cured of hepatitis C does not mean she is immune to reinfection?

The hepatitis C patient who was told she was cured and concluded she was now immune is drawing on the only model most people have for infection and cure: childhood illnesses. Chickenpox: you get it once, you recover, you cannot get it again because your immune system learned to recognize it. That model is true for some infections. It is not true for hepatitis C. “La hepatitis C no funciona como la varicela. Con la varicela, una vez que la tuviste, el sistema inmune aprende a reconocerla tan bien que puede bloquearla si vuelve. La hepatitis C no le enseña al sistema inmune de la misma manera. Los anticuerpos que quedaron en su sangre — los que aparecen en el análisis — son la huella de que tuvo la infección, no un escudo contra una nueva. Si tiene otra exposición — una aguja compartida, la sangre de otra persona — puede volver a infectarse. No es falla del tratamiento. El tratamiento funcionó perfectamente: eliminó el virus que tenía. Lo que no puede hacer el tratamiento es protegerla de un virus nuevo.” The concrete evidence in Consuelo’s case: the new infection is genotype 3. Her original infection was genotype 1a. If this were a treatment failure or a relapse, it would be the same genotype. The genotype change proves she was reinfected, not that the treatment failed. This is important to name explicitly: “Su tratamiento anterior funcionó perfectamente. No falló. Esta nueva infección es un genotipo diferente al que tenía antes — eso nos dice que es una nueva infección, no una recaída de la antigua. Puede tratarse de nuevo. Pero quiero que sepamos cómo pasó para que no pase otra vez.”

What are the Spanish terms for HIV antiretroviral therapy, tuberculosis RIPE treatment, and hepatitis C in infectious disease clinic nursing?

HIV: “VIH” (the Spanish initialism — patients say “el VIH,” “el virus,” sometimes “el SIDA” even when not at AIDS stage). Antiretroviral therapy: “terapia antirretroviral,” “el tratamiento para el VIH,” “los antirretrovirales” — patients say “las pastillas para el VIH,” “el medicamento del doctor,” “la pastilla de todos los días.” Viral load: “carga viral” — patients say “la carga,” “el nivel del virus,” “los números.” Undetectable: “indetectable” — patients say “que no se ve,” “que salió negativo,” sometimes “que desapareció” (the misunderstanding). CD4 count: “recuento de CD4,” “las células CD4” — patients say “los CD4,” “las defensas,” “las células del sistema inmune.” U=U: “indetectable igual a intransmisible” — patients may say “que no puedo transmitirlo,” “que no contagio.” Tuberculosis: “tuberculosis,” “TB” — patients say “la tuberculosis,” “la TB,” sometimes “el mal de pulmones” in older patients. RIPE therapy: “tratamiento con cuatro medicamentos” — patients say “las cuatro pastillas,” “el tratamiento de la TB.” Rifampin: “rifampicina” — patients notice the orange-red urine, tears, and sweat. Isoniazid: “isoniacida,” “INH” — patients say “la pastilla para el hígado” if they were warned about hepatotoxicity. Pyrazinamide: “pirazinamida” — patients may say “la que duele en las articulaciones” (joint pain side effect). Ethambutol: “etambutol” — patients may say “la del ojo” if warned about optic neuritis. Directly observed therapy: “terapia observada directamente,” “DOT” — patients say “que vengo a tomar las pastillas aquí.” Dormant bacteria: “bacterias dormidas” — no clinical equivalent in patient vocabulary; this phrase needs to be explained, not assumed. Hepatitis C: “hepatitis C” — patients say “la hepatitis,” “el virus de la hepatitis C.” SVR12: “respuesta virológica sostenida” — patients say “que me curaron,” “que ya no tengo el virus.” Reinfection: “reinfección,” “una nueva infección” — patients say “que me volvió a dar,” “que me volvieron a contagiar.” Genotype: “genotipo” — patients rarely know this term; it becomes important when explaining that the new infection is provably different from the original one. Jaundice: “ictericia,” “que se pone amarilla la piel” — patients say “que me puse amarilla,” “los ojos amarillos,” “que se me vino lo amarillo.”

Spanish for infectious disease clinic nurses: the patient with HIV who stopped his antiretroviral therapy because he heard that undetectable means cured, the patient with tuberculosis who stopped her RIPE therapy at week five because she felt better and did not know the first two months only suppress symptoms, and the patient with hepatitis C who completed treatment and believes she cannot be reinfected

2026-07-03 · ~28 min read · ClinicaLingo blog

Rafael Ortega had been on bictegravir/emtricitabine/tenofovir alafenamide for eighteen months. Before that, the six months after diagnosis had been difficult — not physically but administratively, the experience of learning to build a life around a daily medication, a quarterly blood draw, a relationship with a clinic he had never planned to have. He was thirty-four, a restaurant line cook who worked the morning prep shift at a hotel kitchen in Phoenix, on his feet at 5 AM five days a week, and taking one pill every evening at the same time had eventually become as automatic as setting the alarm.

His viral load had been undetectable for fourteen consecutive months. His CD4 count at diagnosis had been 340 cells per microliter. It was now 680. The ID clinic nurse had spoken with him at each of the last four quarterly visits and had the impression of a patient who had settled into his treatment without drama or complaint.

In April, his brother-in-law Eduardo had sent him an article. The article was about the U=U campaign — Undetectable equals Untransmittable. It explained that a person with HIV on antiretroviral therapy who maintains an undetectable viral load cannot sexually transmit the virus. Eduardo had added a message: “Rafael — ¿ves? Indetectable quiere decir curado. Ya no necesitas esas pastillas.”

At his last visit, Rafael had asked his prescriber whether he still needed the medication if he was undetectable. The prescriber had said yes, you need to take it every day. Rafael had not understood why. He had taken the answer to mean the prescriber was being cautious — that she was telling him the standard answer without knowing his specific situation. Eight weeks before this quarterly visit, he had stopped the Biktarvy.

He arrived for his routine follow-up. He had filled out the pre-visit questionnaire in the waiting room. He had checked the box next to “yes, taking all medications as prescribed.” The nurse had the lab result from that morning before she entered the room. Viral load: 2,400 copies per milliliter.

Three outpatient infectious disease clinic patterns that arrive dressed as good news: Rafael, thirty-four, on antiretroviral therapy for HIV with fourteen consecutive months of undetectable viral load who stopped his medication eight weeks ago after his brother-in-law read an article about U=U and told him indetectable meant cured — viral load this morning 2,400 copies per milliliter; Guadalupe Méndez, fifty-eight, a domestic cleaner from Dallas with smear-positive pulmonary tuberculosis on four-drug RIPE therapy who stopped all four medications at week five when her night sweats cleared, her cough quieted, and she felt, for the first time in months, completely well, not knowing that the two months that made her feel better were killing the actively-dividing bacteria and that the four months that follow are for the dormant ones she cannot feel; and Consuelo Vargas, fifty-one, a hotel housekeeper from Miami who completed sofosbuvir/velpatasvir for hepatitis C genotype 1a, achieved sustained virologic response twelve weeks after treatment, was told she was cured, and who returns now with two weeks of fatigue and jaundice and a hepatitis C RNA of 1.1 million international units per milliliter — genotype 3, a different strain than the original genotype 1a — because she shared a needle once at a quinceañera party three months ago and believed that being cured meant she was protected from reinfection.

The patient with HIV who stopped his antiretroviral therapy because he heard that undetectable means cured

The nurse began the way she always began: asking how he had been since the last visit. Rafael said he had been fine. Good energy. No complaints. She asked about the medication. He said he was taking it.

She pulled the lab result up on her screen and turned it toward him.

“El análisis de hoy salió con una carga viral de 2,400 copias por mililitro. En sus últimos cuatro visitas, su carga viral estaba indetectable — menos de 20 copias. Algo ha cambiado. ¿Puede contarme cómo ha estado tomando el Biktarvy últimamente?”

A pause. Then: “Pues, mire — en realidad lo dejé hace como dos meses. Me enteré de algo y quise preguntarle hoy.”

“¿Qué fue lo que se enteró?”

He explained the article. Eduardo’s message. The logic: if indetectable meant untransmittable, and untransmittable meant the virus was not active, then wasn’t that the same as being cured? “Y cuando le pregunté a la doctora si todavía necesitaba el medicamento, me dijo que sí. Pero no me explicó por qué. Pensé que era la respuesta de siempre, no la respuesta para mi situación específica.”

The nurse set down her pen. “Lo que leyó sobre indetectable igual a intransmisible es real — es verdad. Cuando el virus está indetectable con el medicamento, no puede transmitirse sexualmente. Eso es exacto y es una de las razones más importantes por las que existe el tratamiento. Lo que su cuñado entendió — lo que muchas personas entienden cuando leen eso — es que indetectable significa que el virus desapareció. Eso no es lo que significa. ¿Le puedo explicar la diferencia?”

“Sí, por favor. Por eso vine.”

“Cuando usted toma el Biktarvy todos los días, el medicamento bloquea la capacidad del VIH de reproducirse. El virus no puede copiarse. Sin copias nuevas, la cantidad de virus en su sangre cae tan bajo que los equipos más sensibles que tenemos no pueden detectarlo — por eso decimos indetectable. Pero el virus no se fue. Hay células del sistema inmune — células CD4, macrófagos — que fueron infectadas hace años y que tienen copias del virus guardadas en su interior, dormidas. El medicamento no llega a esas células de la misma manera. No puede eliminar lo que ya está escondido adentro. Cuando usted toma el medicamento todos los días, esas células permanecen dormidas y el virus no puede circular. Cuando para el medicamento, esas células despiertan y el virus empieza a reproducirse de nuevo.”

Rafael was looking at the number on the screen. “Las 2,400 copias de hoy.”

“Exactamente. En dos meses sin el medicamento, pasó de indetectable a 2,400. Eso no es falla del tratamiento — es el tratamiento ausente. El medicamento estaba haciendo el trabajo de mantener el virus en ese estado donde no se puede detectar y no puede transmitirse. En cuanto lo quitó, el virus retomó la reproducción. Dos meses. Y ahora es detectable, lo cual significa que ya no aplica el indetectable igual a intransmisible mientras tanto.”

That last part landed. “¿O sea que ahora sí puedo transmitirlo?”

“Con una carga viral de 2,400, sí — el riesgo de transmisión existe. No es extremadamente alto a esa carga, pero no es cero. Indetectable es el objetivo precisamente porque a esa cifra el riesgo es cero. Lo que su cuñado leyó era correcto sobre la transmisión. Pero lo que no dijo el artículo es que indetectable solo existe mientras el medicamento está funcionando. Deje el medicamento y deja de ser indetectable.”

“¿Cuánto tiempo para volver a ser indetectable si empiezo de nuevo hoy?”

“Con Biktarvy, la mayoría de las personas vuelven a indetectable en cuatro a seis semanas. Usted estuvo indetectable catorce meses consecutivos antes de parar — su sistema respondió muy bien. Empezamos hoy y revisamos la carga viral en seis semanas para confirmarlo.”

The nurse also told him that there is no cure for HIV yet — not because research is not trying, but because the reservoir of dormant infected cells has proven extremely difficult to eliminate. The goal of antiretroviral therapy is not cure; it is lifelong suppression. Indetectable is what that suppression looks like from the outside. It is the evidence that the medication is working, not the evidence that the virus is gone.

She also asked about Eduardo. “¿Hay alguien en su vida — su cuñado, su pareja, amigos — a quien le gustaría que explicáramos esto directamente, para que no le lleguen mensajes que lo hagan dudar del tratamiento?”

Rafael thought about this. “Eduardo lo hizo con buenas intenciones. No supo que estaba equivocado en la parte importante.”

“Exactamente. Y ese mensaje le costó dos meses y una carga viral de 2,400. La próxima vez que alguien le diga algo sobre el tratamiento, dígales que hable conmigo o con la doctora antes de que usted tome una decisión. No por desconfiar de ellos — por protegerse de buenas intenciones sin contexto clínico.”

Rafael restarted Biktarvy that afternoon. His viral load at six weeks: undetectable. At twelve weeks: undetectable. At twenty-four weeks: undetectable. CD4 at six months: 712. “No sabía que indetectable y curado eran dos cosas distintas. Eduardo tampoco. El artículo que leí no lo decía.”

The patient with tuberculosis who stopped her RIPE therapy because she started feeling better and did not know the first two months only suppress symptoms

Guadalupe Méndez had been coughing for eleven weeks before her PCP ordered the sputum smear. She had attributed the cough to the dust from the cleaning supplies she used at the apartment complex where she worked — eight units a day, shared cleaning cart, no mask. By the time the smear came back, she had lost nine pounds and was waking at 2 AM soaked.

The county TB clinic had been efficient. She was started on rifampin 600 mg, isoniazid 300 mg, pyrazinamide 1,500 mg, and ethambutol 1,200 mg on the day the culture sensitivity results confirmed drug-sensitive tuberculosis. The clinic used directly observed therapy: she came in three times a week and a community health worker brought the medication to her on the other days.

By week three, the night sweats had stopped. Her cough, which had been productive for months — thick, yellowish sputum she would clear in the bathroom at 6 AM before starting work — had quieted to an occasional dry clearing of the throat. Her appetite had returned. She had gained two pounds. She felt, she said later, “completamente normal por primera vez en cuatro meses.”

At week four, the community health worker arrived on a Tuesday morning with the four medications. Guadalupe had been going to the clinic on Monday, Wednesday, Friday; the home visit was for Thursday. She had taken the pills. But on the Friday of week five, she did not come to the clinic. The community health worker called on Saturday. Guadalupe said she had felt fine for two weeks now, the pills were harsh, the rifampin was making her urine orange in a way that alarmed her each morning even though she had been told it would, and she had decided that if she felt completely well, the infection must be gone.

“Ya me curé. Ya no sentía nada, entonces las dejé.”

The clinic brought her in for a week-seven visit. The nurse who had done her initial intake was the one who received her. Guadalupe arrived looking well. She did, in fact, look well. Her weight was up two more pounds from the last measurement. Her oxygen saturation was 97%. She was not coughing.

The nurse did not begin with the instruction to restart. She began with what Guadalupe knew about why the treatment lasted six months.

“Señora Méndez, me alegra mucho verla mejor — los síntomas que tenía al principio eran muy serios. Cuando me dijo por teléfono que decidió parar porque se sentía bien, entendí. Lo que quiero hacer hoy es explicarle cómo funciona el tratamiento de la tuberculosis, porque lo que pasó en su cuerpo en estas primeras semanas es exactamente lo que debería pasar, pero no es el final de la historia. ¿Le parece bien?”

“Dígame. Yo pensé que estaba curada.”

“Eso es exactamente lo que quiero explicarle. La bacteria de la tuberculosis — el Mycobacterium tuberculosis — tiene dos modos de existir dentro del pulmón. Hay bacterias que están activas: se están multiplicando, están causando inflamación, producen los síntomas que usted tenía — la tos con flema, la fiebre, el sudor nocturno, la pérdida de peso. Esas son las que atacan los primeros dos meses de tratamiento. Los cuatro medicamentos juntos las matan rápidamente — por eso en tres o cuatro semanas usted se siente normal. Los síntomas desaparecen porque las bacterias activas están muriendo. Eso es bueno. Eso es el tratamiento funcionando exactamente como debe.”

Guadalupe was listening carefully. “Entonces ¿por qué no termina ahí?”

“Porque hay un segundo grupo de bacterias. Dentro del pulmón, dentro de unas áreas donde el sistema inmune las encerró, hay bacterias que están dormidas. No se están multiplicando. No producen síntomas. No las siente. Pero están vivas. Las bacterias dormidas no las matan los primeros dos meses del mismo modo que las activas, porque los medicamentos actúan mejor contra las bacterias que se están dividiendo rápido. Para las dormidas, se necesita tiempo — cuatro meses más de rifampicina e isoniacida, que son las que mejor penetran esos lugares donde están escondidas. Si para el tratamiento cuando se siente bien — cuando las activas murieron pero las dormidas todavía están ahí — las dormidas despiertan. Semanas más tarde, o meses. Y cuando despiertan, la enfermedad vuelve.”

“¿Y por qué no simplemente empiezo el tratamiento de nuevo cuando vuelva?”

The nurse paused. This was the part that mattered most.

“Porque las bacterias que sobrevivieron al tratamiento incompleto no son exactamente las mismas que estaban antes. La tuberculosis tiene una capacidad especial: cuando las bacterias están expuestas a los medicamentos pero no se matan completamente — porque el tratamiento se interrumpe — las que sobreviven pueden volverse resistentes. Han visto el medicamento, han aprendido a tolerar un poco. La segunda vez, el tratamiento estándar puede no funcionar igual. Eso se llama tuberculosis resistente a medicamentos — o en los casos más serios, tuberculosis multirresistente. El tratamiento para esa forma dura dieciocho a veinticuatro meses, usa medicamentos inyectables, y tiene efectos secundarios mucho más serios. No quiero asustarlo — quiero que entienda por qué los seis meses no son arbitrarios. Son exactamente el tiempo que se necesita para no dejarle escapatoria a ninguna de las dos formas de la bacteria.”

Guadalupe was quiet. “¿O sea que lo que yo hice — parar en la quinta semana — pudo haberme creado una tuberculosis más difícil de tratar?”

“Es el riesgo. No sabemos todavía — vamos a hacer un cultivo nuevo para ver si hay alguna señal de resistencia. Cinco semanas de tratamiento parcial es mejor que nada, y usted vino hoy en vez de desaparecer. Eso importa. Lo que necesitamos hacer ahora es reiniciar, completar los seis meses desde el punto en que estamos, y monitorear el cultivo. Si las bacterias todavía son sensibles — que es lo que esperamos — continuamos con el mismo régimen. Si hay alguna resistencia, ajustamos a tiempo.”

The nurse also addressed the rifampin side effects directly. The orange urine, the orange tears, the occasional orange tinge in sweat. She had covered this at the first visit but knew it had been information overload. “El color naranja es la rifampicina saliéndose del cuerpo — es inofensivo, es esperable, y es en realidad una señal de que el medicamento está siendo absorbido y excretado. Si el orín no saliera naranja, diría que el medicamento no está siendo absorbído. Es la señal correcta. Solo que asusta si nadie le dice que es normal.”

Guadalupe restarted RIPE therapy that afternoon. The sputum culture at week eight, after reinitiation: still sensitive to all four drugs. She completed her six months — counted from the restart, extending the total duration to account for the five weeks of interrupted treatment. At her end-of-treatment visit, sputum culture negative. Chest X-ray: residual scarring in the right upper lobe, no active infiltrate. She had been on directly observed therapy for the entirety of her remaining treatment.

“Nadie me explicó lo de las bacterias dormidas. Si me lo hubieran dicho al principio — que iba a sentirme bien y que eso era la primera parte funcionando, no el final — no las habría dejado.”

The patient with hepatitis C who was cured by treatment and believes she cannot be reinfected

Consuelo Vargas had been told she was cured, and she had believed it the way a person believes good news they have been waiting to hear for three years. She had been diagnosed with hepatitis C genotype 1a at a routine health screening at her union hall — she worked for a hotel housekeeping contractor in Miami — and had spent six months on a waitlist for a patient assistance program before she could access sofosbuvir/velpatasvir. Twelve weeks of treatment. Undetectable hepatitis C RNA at end of treatment. At the twelve-week post-treatment visit, sustained virologic response confirmed. Her provider had said: “El virus ya no está. Está curada.”

She had understood this the way she understood any cure: the way you understand that you had pneumonia once and no longer have it; that you had the flu one winter and your body had learned to handle it. She had the impression, which no one had corrected, that her immune system had learned to recognize and fight off the hepatitis C virus. That the antibodies that remained were a shield, not just a scar.

At a quinceañera party in January — three months before this visit — a situation had arisen at the end of the night that she had not expected to be in and would not have anticipated needing to protect herself from. She had shared a needle with a person she knew. She had thought, in the moment: “Para eso me curaron — para que esto no me afecte.”

She had noticed the fatigue gradually in February. She had attributed it to the heavy cleaning schedule after the post-New Year rush, the hotel at near capacity through the spring. By March, she was noticing that the whites of her eyes looked slightly yellow in the bathroom mirror in the morning. She had come to the ID clinic because she did not want to wait and because she knew, in a way she had not let herself think too precisely, what the yellow eyes might mean.

The hepatitis C RNA had come back that morning: 1.1 million international units per milliliter. Genotype 3.

The nurse entered the room and sat down. She did not begin with the result immediately. She asked Consuelo how she had been since her last visit.

Consuelo: “Cansada. Y los ojos — los tenía amarillos esta mañana. Ya lo sabía antes de venir. Que volvió.”

“El análisis de hoy mostró que hay hepatitis C en su sangre. Quiero explicarle lo que significa el resultado, porque hay algo importante en él que no es lo que parece a primera vista.”

Consuelo: “Que el tratamiento no funcionó.”

“No. El tratamiento funcionó perfectamente. Su respuesta virológica sostenida de hace seis meses fue real — el virus de la hepatitis C que usted tenía en ese momento fue eliminado. Lo que el análisis de hoy muestra no es el mismo virus regresando. Es un virus diferente. La hepatitis C de hoy es genotipo 3. La que tenía antes era genotipo 1a. Son cepas distintas. Eso significa que no es una recaída del tratamiento anterior — es una nueva infección.”

Consuelo was very still. “¿Cómo es posible? Me dijeron que estaba curada.”

“Está curada de la primera infección. Lo que no le explicaron — y deberían haberlo hecho — es que curarse de la hepatitis C no es lo mismo que volverse inmune a ella. La hepatitis C no funciona como la varicela. Con la varicela, una vez que la tuviste, el sistema inmune aprende a reconocerla de una manera que previene la reinfección. La hepatitis C no le enseña al sistema inmune de la misma manera. Los anticuerpos que quedan en su sangre después del tratamiento — los que siempre van a aparecer positivos en la prueba de anticuerpos, el resto de su vida — son la huella de que tuvo la infección. No son un escudo contra una nueva.”

“¿El resto de mi vida?”

“Los anticuerpos de la hepatitis C permanecen positivos indefinidamente después de una infección, incluso después del tratamiento exitoso. Eso no significa que esté infectada — significa que el sistema inmune guardó el registro. El análisis que confirma si hay infección activa es el RNA — el que hicimos hoy. Cuando está curada, el RNA es indetectable. Los anticuerpos son solo historia. La historia de que tuvo el virus y lo venció.”

Consuelo had tears in her eyes. “Pensé que estar curada me protegía.”

“Eso es lo que la mayoría de las personas entienden cuando escuchan ‘curada’ — porque es lo que la palabra significa para casi todas las enfermedades. No era una conclusión errónea. Era la única conclusión disponible con la información que le dieron. La hepatitis C es la excepción. El sistema inmune no aprende a bloquearla de la misma manera que bloquea la varicela o la influenza después de la vacuna. Puede volver a infectarse — con el mismo genotipo, con un genotipo diferente. Personas que se curan de la hepatitis C a veces se reinfectan más de una vez si las exposiciones continúan.”

The nurse asked, without preamble and without blame, what Consuelo thought might have been the exposure. Consuelo told her about January. The party. The needle. “Creí que estaba a salvo porque estaba curada.”

“Entiendo. Y quiero que sepamos que no fue una decisión descuidada — fue una decisión basada en información que estaba incompleta. Esa diferencia importa porque lo que hacemos ahora no es castigar la decisión — es asegurarnos de que la información esté completa para adelante.”

She also addressed the jaundice — the yellow eyes. Genotype 3 hepatitis C tends to cause more liver inflammation than genotype 1a, which explained why this infection was symptomatic in a way the original had not been when she was first diagnosed. She ordered a liver function panel, an abdominal ultrasound, and a referral to hepatology for treatment planning. Genotype 3 responds well to sofosbuvir/velpatasvir, the same regimen she had received before — but the hepatologist would confirm the appropriate regimen and duration given the new fibrosis staging.

The nurse also provided harm reduction information for the future: never sharing needles, syringes, cotton, water, or equipment regardless of perceived immune status, and the location of the county syringe service program. She did this matter-of-factly, not as a sanction. “Le voy a dar la dirección del programa de agujas del condado — es confidencial y gratuito. No porque piense que usar drogas está bien o mal — es porque si alguna vez vuelve a estar en esa situación, quiero que tenga una aguja limpia. La hepatitis C no merece una segunda ronda.”

Consuelo completed treatment. Genotype 3, sofosbuvir/velpatasvir for twelve weeks. SVR12 confirmed. Liver function normal at end of treatment.

At the post-treatment visit, the nurse reviewed the immunity question one more time — not as a correction, but as a consolidation. “La hepatitis C que tenía antes: curada. La de enero: curada también. Los anticuerpos van a estar positivos para siempre, que es normal. El RNA — el que importa para saber si hay infección activa — está indetectable. Eso es curación. Y sigue siendo posible reinfectarse. La diferencia ahora es que usted lo sabe.”

“La primera vez, nadie me dijo eso. Pensé que la hepatitis C era como la gripa — que una vez que la pasas, el cuerpo sabe. No sabe.”

The three questions for every infectious disease clinic visit with a Spanish-speaking patient

The three encounters above share a structure. Rafael had been on treatment for eighteen months and doing well until a piece of real science, communicated without the distinction that would have made it safe to receive, produced a medically coherent error. Guadalupe had been taking four medications on a schedule that was hard to maintain for a reason that had been explained to her without the mechanism — the dormant bacteria, the two-phase model — that would have made the duration comprehensible rather than arbitrary. Consuelo had been cured of an infection and had not been given the one fact about hepatitis C that differs from every other infection she had ever encountered: that cured does not mean immune.

Three questions that find them before the viral load, the sputum culture, or the jaundice does:

“¿Ha habido algún día o semana en que no tomó el medicamento — o en que lo tomó diferente de como se lo recetaron? No importa la razón — a veces se olvida, a veces hay una razón. Me ayuda saber.”

This question is different from “¿está tomando todos sus medicamentos?” The closed question can be answered with a yes that is technically true in the patient’s understanding even when it is not. Rafael had checked “yes” on the form because he believed stopping was rational given what he had read, not because he was trying to deceive the clinic. The open question — “has there been any day or week” — asks about behavior across time rather than about a current state. The phrase “no importa la razón” signals that the nurse is not looking for a confession; she is looking for information. “A veces se olvida, a veces hay una razón” names two very different causes of non-adherence and normalizes both, which lowers the threshold for disclosing a deliberate decision the patient may have made with genuine logic behind it.

“¿Cómo le explicó el doctor la duración del tratamiento — cuántos meses total y qué pasa durante cada parte?”

The tuberculosis patient who stops at symptom resolution has almost always been told the duration. She was told six months. What she was not told was the mechanism that makes six months necessary when the symptoms are gone at four weeks. This question asks not whether the patient was told the duration but how the duration was explained to her — and specifically whether she understands what happens in each phase. The answer that reveals the gap is not “the doctor said six months” — it is what comes after: “but I felt well at week five and I thought that meant it was over.” That answer is the beginning of the conversation about dormant bacteria and the two-phase model. The question that does not ask about understanding cannot produce that answer.

“¿Le ha explicado alguien qué significa haber completado el tratamiento de la hepatitis C — qué está protegida de y qué no?”

This question is asked at the SVR12 visit — the cure confirmation visit — not six months later in the emergency department. The patient who is told she is cured at SVR12 and nothing else leaves with a word that, in every context she has ever encountered it, means immune. The question asks specifically about what was explained about what the cure protects against and what it does not — which is the only framing that surfaces the immunity assumption before it leads to a behavior. The patient who says “me dijeron que estaba curada” and stops there has not received the half of the sentence that would have protected her. The nurse who asks this question at the right moment gives the patient the second half.

The practice at ClinicaLingo covers these and similar conversations across thirty clinic and ED encounters. The post on medication reconciliation in Spanish covers the systematic approach to finding what the patient stopped, why, and when — the three categories that appear across Rafael, Guadalupe, and Consuelo — and the phrasing that distinguishes a deliberate decision from a missed dose from a logical conclusion drawn from incomplete information. The post on how to explain a diagnosis in Spanish covers the mechanism-first framing for conditions where the underlying process is invisible to the patient — viral replication in a treated HIV patient, dormant bacteria in a recovering tuberculosis patient, immune memory that does and does not form after specific infections. The post on Spanish for public health nurses covers the contact tracing, TB screening, and STI disclosure conversations that precede the ID clinic follow-up — the upstream encounters where the same patients first encounter the language of communicable disease. The post on Spanish for hematology clinic nurses covers the cost-driven treatment rationing and medication discontinuation based on a social network contact’s experience — structural patterns that appear across specialties, including HIV care, when the medication is expensive or frightening and the patient has a peer whose experience shaped their understanding of the drug.

The 50-phrase PDF covers the intake, pain scale, allergy, and discharge vocabulary most nurses need most often on most shifts. The infectious disease clinic posts cover the patterns that only appear at specific visit types — the HIV patient who read something true and drew an inference that was wrong in the one direction that mattered, the tuberculosis patient who felt well and applied the only model of recovery she had ever needed before, and the hepatitis C patient who received a cure and was not told what cured does not mean.

In all three cases, the information that would have prevented the clinical event was simple. Not technical. Not beyond the capacity of a motivated patient to understand. It was withheld by omission — the conversation that ended at “indetectable” without adding “but not gone,” the treatment plan that included six months without explaining what happens in each half, the cure announcement that stopped before “but not immune.” The nurse who asks what the patient understood is the person who discovers what was left out — and who can add it before the viral load comes back, before the culture shows resistance, before the genotype tells the story of a needle shared by someone who thought she was safe.